Drawing for CHONG KUN DANG

USPTO serial 88470347

CHONG KUN DANG

Reviewed by CopyMark Law Group

Reg. 6166899Status 702Renewal
Filing date
Status date
Registration date
Oct 6, 2020
Examiner
LEVINE, HOWARD B
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with CHONG KUN DANG?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $425

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael T. Smith

Michael T. Smith BIRCH, STEWART, KOLASCH & BIRCH, LLP2600 Park Tower Drive, Suite 600Vienna, VA 22180United States

Goods and services

ClassDescriptionStatusFirst use
005[ Vitamin preparations; Antibiotic preparations; Pharmaceutical agents affecting digestive organs; Pharmaceutical preparations for treating respiratory diseases; Allergy medications; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations acting on the central nervous system; Cardiovascular agents for medical purposes; Amino acids for medical purposes; Dermatological pharmaceutical preparations; Ophthalmic preparations; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for immunity adjustment; Pharmaceutical preparations, namely, antivirals; Tumor suppressing agents; Pharmaceutical preparations for treating hypertension; pharmaceutical preparations for the treatment of hyperlipidemia; Anti-inflammatories; Analgesics; Bacterial poisons; Pharmaceutical preparations for the treatment of cellular disorders; Pharmaceutical preparations for the treatment of bone diseases; Pharmaceutical preparations for use in urology; Vaccines; Nutritional supplements, namely, tonics and alternatives for medical purposes; Antibiotics; pharmaceutical preparation for the arthritis treatment; pharmaceutical preparation for the rheumarthritis treatment; Anti-cancer preparations; Pharmaceutical preparations for the prevention of cancer; Pharmaceutical preparations for the treatment of cancer; Health food supplement mainly based on lactic acid bacteria; ] Nutritional supplements, namely, probiotic compositions; [ Lactic acid bacteria in the form of capsules for medical purpose; Lactose for medical purposes; Powdered milk for babies; Calcium supplements; Powdered nutritional supplement drink mixes; ] Probiotic supplements; [ Pharmaceutical preparations for use in the treatment of diabetes, anemia, cardiovascular disease, weight loss, hormone replacement, nutritional deficiencies, infectious disease, autoimmune disease, fatigue, inflammation, pain, environmental toxicities, and heavy metal toxicities; Nutraceutical preparations for therapeutic or medical purposes in the treatment of gout; nutraceuticals for use as a dietary supplement; Anti-oxidant food supplements; Food supplements, namely, anti-oxidants; ] Food supplements [; Dietary supplements; Medicated food supplements ]ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 21, 2026NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jul 21, 2026C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jul 21, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 16, 2026E815TEAS SECTION 8 & 15 RECEIVED—
Oct 6, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 6, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 2, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 2, 2020EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Sep 2, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 2, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 21, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 21, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 1, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 12, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 11, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 11, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 10, 2020ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Apr 1, 2020GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 1, 2020GNSLLETTER OF SUSPENSION E-MAILED—
Apr 1, 2020CNSLSUSPENSION LETTER WRITTEN—
Mar 11, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 11, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 9, 2020ALIEASSIGNED TO LIE—
Mar 3, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 5, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 5, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 5, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 4, 2019DOCKASSIGNED TO EXAMINER—
Jun 25, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 15, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance